Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patricia M. Miron
Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Related publications
Micafungin Prophylaxis for Acute Leukemia Patients Undergoing Induction Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Efficacy and Toxicity of Idarubicin Versus High-Dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia
Journal of Pediatric Hematology/Oncology
Child Health
Oncology
Pediatrics
Hematology
Perinatology
Secondary Acute Myeloid Leukemia (sAML) Immediately After Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)
Journal of Leukemia
High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia
Cancer Cell International
Cancer Research
Oncology
Genetics
VATS Pneumonectomy After Induction Chemotherapy
Journal of Clinical and Analytical Medicine
Medicine
